Fundz

Velentium Medical secures a growth investment led by 1315 Capital to support expansion and product development. The investment will enhance manufacturing operations and infrastructure in the medical device market.

PRIVATESep 23, 2026

Round Type

Venture

RichmondManufacturingBiotechnologyHealth CareMedicalMedical Device

Investors

1315 Capital

Description

Velentium Medical, a leader in medical technology, announced a growth capital investment led by 1315 Capital. This funding will support the expansion of its commercial manufacturing operations and enhance its product development capabilities. The investment also aims to improve automation and infrastructure as part of strategic growth opportunities. Great Point Partners continues to be a significant shareholder following this transaction.

Quick answer

Velentium Medical raised an undisclosed amount in a funding round, dated September 23, 2026. Investors: 1315 Capital. Velentium Medical is based in Richmond, Texas, United States.

How much did Velentium Medical raise?
Velentium Medical raised an undisclosed amount in a funding round on September 23, 2026.
Who invested in Velentium Medical?
1315 Capital is named as investors in this round.
What does Velentium Medical do?
Velentium Medical is a full-service medical technology innovation, development, and manufacturing company focused on helping customers transform innovative ideas into market-leading medical devices.
Where is Velentium Medical based and how big is it?
Velentium Medical is based in Richmond, Texas, United States. Fundz records about 84 employees.
Who are the decision-makers at Velentium Medical?
Fundz holds 3 contacts at Velentium Medical, including the Chief Commercial Officer (CCO). Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Velentium Medical that raised within 45 days of this round, from Fundz verified event records.

  • Total Joint Orthopedics raised $11M (Debt Financing) on October 21, 2026.
  • Nami Surgical raised $4.5M (Series A) on October 13, 2026.
  • Scarlet raised $50M (Series B) on October 12, 2026.
  • Encision raised $80K (Post-IPO Equity) on September 8, 2026.
  • Tenon Medical raised $4.3M (Series A) on August 31, 2026.
  • Tenon Medical raised $3M (Post-IPO Equity) on August 28, 2026.

Who to call at Velentium Medical, and when

A new round usually means Velentium Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Velentium Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Velentium Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Velentium Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Velentium Medical

Location

Richmond, Texas, United States

About

Velentium Medical is a full-service medical technology innovation, development, and manufacturing company focused on helping customers transform innovative ideas into market-leading medical devices. The company provides highly integrated expertise across product strategy, research, design and development, automated test, cybersecurity, and manufacturing under one roof in Richmond, Texas. Velentium Medical serves customers ranging from emerging growth companies to global medical technology leaders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Velentium Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsNate P., Chief Commercial Officer (CCO) hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Velentium Medical's next move

See what Strategic adds

Velentium Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.